Key Insights

Highlights

Success Rate

82% trial completion

Clinical Risk Assessment

Based on trial outcomes

High Risk

Score: 72/100

Termination Rate

10.6%

7 terminated out of 66 trials

Success Rate

81.6%

-4.9% vs benchmark

Late-Stage Pipeline

8%

5 trials in Phase 3/4

Results Transparency

29%

9 of 31 completed with results

Key Signals

9 with results82% success

Data Visualizations

Phase Distribution

51Total
Not Applicable (21)
Early P 1 (1)
P 1 (11)
P 2 (13)
P 3 (3)
P 4 (2)

Trial Status

Completed31
Recruiting16
Unknown8
Terminated7
Withdrawn2
Active Not Recruiting1

Trial Success Rate

81.6%

Benchmark: 86.5%

Based on 31 completed trials

Clinical Trials (66)

Showing 20 of 20 trials
NCT05428358Not ApplicableRecruiting

Incremental Value of Magnetic Resonance Imaging in Selection of Pancreatic Cancer Patients for Surgery

NCT05687123Phase 1Recruiting

Testing the Addition of Sunitinib Malate to Lutetium Lu 177 Dotatate (Lutathera) in Pancreatic Neuroendocrine Tumors

NCT06807437Phase 3Recruiting

Lanreotide Versus Placebo Before Surgery to Prevent a Surgical Complication Called a Pancreatic Fistula

NCT05961982Not ApplicableRecruitingPrimary

Evaluation of Endoscopic Ultrasound-Guided Radiofrequency Ablation for the Management of Pancreatic Tumors, ERASE Study

NCT06051695Phase 1Recruiting

A Study to Evaluate the Safety and Efficacy of Mesothelin-Targeting Logic-gated CAR T, in Participants With Solid Tumors That Express MSLN and Have Lost HLA-A*02 Expression

NCT04693754Enrolling By InvitationPrimary

Endoscopic Ultrasound Radiofrequency Ablation, Database Repository

NCT06526442RecruitingPrimary

MRE for Diagnosis of Pancreatic Masses

NCT07396662RecruitingPrimary

Endocrine-exocrine Functions and Prognosis After Pancreatectomy

NCT07382791RecruitingPrimary

Delayed Gastric Emptying After Pancreatic Surgery

NCT06411795Phase 2Recruiting

Rectus Sheath Block With Liposomal Bupivacaine Versus Thoracic Epidural Analgesia for Pain Control Following Pancreatoduodenectomy

NCT06400472Phase 1Recruiting

A Study of LY4170156 in Participants With Selected Advanced Solid Tumors

NCT07257523Phase 2RecruitingPrimary

Carbon Ion Radiotherapy in Frail Patients With Pancreatic Cancer

NCT05786716Phase 2Recruiting

DETERMINE Trial Treatment Arm 04: Trastuzumab in Combination With Pertuzumab in Adult, Paediatric and Teenage/Young Adult Patients With Cancers With HER2 Amplification or Activating Mutations

NCT07252570Completed

Portal Vein Stenting for Malignant Obstruction: Feasibility, Safety, and Clinical Outcomes

NCT07045181Completed

Prediction Model of Pancreatic Neoplasms in CP Patients With Focal Pancreatic Lesions

NCT03033225Phase 2Completed

Ultrasound-Guided Verteporfin Photodynamic Therapy for the Treatment of Unresectable Solid Pancreatic Tumors or Advanced Pancreatic Cancer, VERTPAC-02 Study

NCT07045571RecruitingPrimary

MSCAN: ctDNA Methylation as Prognostic and Theranostic Tool for Pancreatic Cancer

NCT06545344Not ApplicableWithdrawnPrimary

Palliative Care Consultation to Improve Communication for Patients Considering Surgery for a Pancreatic Neoplasm

NCT06122896Early Phase 1Recruiting

Prospective Screening for Pancreatic Ductal Adenocarcinoma in High-Risk Individuals

NCT05222204Phase 2CompletedPrimary

DDP ip Combined With AG in PDAC With Peritoneal Metastasis

Scroll to load more

Research Network

Activity Timeline